402 related articles for article (PubMed ID: 17119378)
1. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
[TBL] [Abstract][Full Text] [Related]
2. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein on admission as a predictor of in-hospital death in the elderly with acute myocardial infarction.
Gheno G; Libardoni M; Zeppellini R; Cucchini F
Cardiologia; 1999 Dec; 44(12):1023-8. PubMed ID: 10687251
[TBL] [Abstract][Full Text] [Related]
5. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
[TBL] [Abstract][Full Text] [Related]
6. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
[TBL] [Abstract][Full Text] [Related]
7. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
[TBL] [Abstract][Full Text] [Related]
8. Acute-phase reactants in acute myocardial infarction: impact on 5-year prognosis.
Mariotti R; Musumeci G; De Carlo M; Biadi O; Caravelli P; Limbruno U; Mariani M
Ital Heart J; 2001 Apr; 2(4):294-300. PubMed ID: 11374499
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
[TBL] [Abstract][Full Text] [Related]
10. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
11. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention.
Ortolani P; Marzocchi A; Marrozzini C; Palmerini T; Saia F; Taglieri N; Baldazzi F; Silenzi S; Bacchi-Reggiani ML; Guastaroba P; Grilli R; Branzi A
Eur Heart J; 2008 May; 29(10):1241-9. PubMed ID: 17766280
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty.
de Winter RJ; Heyde GS; Koch KT; Fischer J; van Straalen JP; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; Piek JJ; Tijssen JG
Eur Heart J; 2002 Jun; 23(12):960-6. PubMed ID: 12069451
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries).
Segev A; Strauss BH; Tan M; Mendelsohn AA; Lai K; Ashton T; Fitchett D; Grima E; Langer A; Goodman SG;
Am J Cardiol; 2006 Aug; 98(4):470-3. PubMed ID: 16893699
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.
Bodí V; Sanchis J; Llàcer A; Fácila L; Núñez J; Bertomeu V; Pellicer M; Chorro FJ
Int J Cardiol; 2005 Feb; 98(2):277-83. PubMed ID: 15686779
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
19. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
Bodí V; Sanchis J; Llàcer A; Fácila L; Núñez J; Pellicer M; Bertomeu V; Ruiz V; Chorro FJ
Am Heart J; 2005 Feb; 149(2):268-74. PubMed ID: 15846264
[TBL] [Abstract][Full Text] [Related]
20. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris.
Doo YC; Han SJ; Lee JH; Cho GY; Hong KS; Han KR; Lee NH; Oh DJ; Ryu KH; Rhim CY; Lee KH; Lee Y
Am J Cardiol; 2004 Mar; 93(5):554-8. PubMed ID: 14996578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
